Ophthalmology Advisor: endophthalmitis up to 11 years

Glaucoma drainage implants are tiny pressure-relief devices, but they create a long-term infection risk that does not end after the postop period. That is the real news here. A new case series in the *American Journal of Ophthalmology* tracked 45 eyes with implant-associated endophthalmitis and showed the infection can show up anywhere from 6 weeks to 11 years after surgery, with a median delay of 4 years. That matters because endophthalmitis is one of the worst eye infections there is — fast, destructive, and often vision-threatening. (pubmed.ncbi.nlm.nih.gov) ### What is the device here? A glaucoma drainage implant, or GDI, is a tube-and-plate shunt used when eye pressure is hard to control with standard surgery or drops. The tube drains fluid from inside the eye to a plate under the conjunctiva, which is the thin tissue covering the white of the eye. It is effective for refractory glaucoma, but the(pubmed.ncbi.nlm.nih.gov)t can later erode or become exposed. (ajo.com) ### Why is this infection such a big deal? Endophthalmitis is infection inside the eye. Once bacteria or fungi get in, damage can happen quickly — not just irritation or redness, but permanent loss of vision and sometimes loss of the eye itself. That is why even a rare complication gets attention here. The study and prior literature both p(ajo.com) away. (pubmed.ncbi.nlm.nih.gov) ### What did the new study actually show? The new series identified 45 eyes from a single center, making it the largest single-center report of post-GDI endophthalmitis in the search results. Onset ranged from 6 weeks to 11 years after implantation, with a median interval of 4 years. Cultures were positive in 51% of cases, and treatment started(pubmed.ncbi.nlm.nih.gov)itrectomy. (ophthalmologyadvisor.com) ### What seems to trigger it? Exposure is the big one. In the new series, 73% of eyes had tube or plate exposure at diagnosis, and another 18% had recent conjunctival revision for prior exposure. Basically, the hardware or the tissue over it had already declared itself unstable. Older reports line up with that pattern too — late infections are repeatedly tied to erosion or exposure of the device. (pubmed.ncbi.nlm.nih.gov) ### Is this common? No. It is rare. Ophthalmology Advisor’s writeup says overall incidence stays below 1%, and older series put it around 0.7% in one cohort of 1,891 implanted eyes. But “rare” is not the same as “short-lived.” The notable thing is not a surge in frequency — it is the very long tail of risk. (ophthalmologyadvisor.com)lant-risk/)) ### Why does the 11-year delay matter? Because it breaks the easy mental model that surgical infection risk is mostly early. With GDIs, the danger window can reopen years later if conjunctival tissue thins, breaks down, or exposes the tube. One older case report even described endophthalmitis 11 (ophthalmologyadvisor.com)ost obvious warning sign. (pmc.ncbi.nlm.nih.gov) ### What should patients and clinicians do with this? The practical takeaway is long surveillance. Patients with drainage implants need to know that new pain, redness, discharge, blurry vision, or a visible tube is urgent even many years after surgery. Clinicians, meanwhile, need to treat tube or plate exposure as a real infection pathway, (pmc.ncbi.nlm.nih.gov)outcomes in prior work, which makes education part of prevention. (journals.lww.com) ### Bottom line The study does not say glaucoma drainage implants are unsafe in general. It says the small infection risk lasts much longer than people think — sometimes more than a decade — and exposed hardware is the clearest warning sign. (pubmed.ncbi.nlm.nih.gov)